Safety and efficacy of panitumumab in combination with trifluridine/tipiracil for pre-treated patients with unresectable, metastatic colorectal cancer with wild-type RAS: The phase 1/2 APOLLON study

Takeshi Kato, Yoshinori Kagawa, Yasutoshi Kuboki, Makio Gamoh, Yoshito Komatsu, Hirofumi Yasui, Hironaga Satake, Eiji Oki, Hiroaki Tanioka, Masahito Kotaka, Akitaka Makiyama, Tadamichi Denda, Masahiro Goto, Takayuki Yoshino, Kentaro Yamazaki, Junpei Soeda, Kazunori Shibuya, Masaru Iwata, Koji Oba, Kensei Yamaguchi

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Safety and efficacy of panitumumab in combination with trifluridine/tipiracil for pre-treated patients with unresectable, metastatic colorectal cancer with wild-type RAS: The phase 1/2 APOLLON study'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science